Internists, family physicians and pediatricians could help slash nearly $7 billion in annual health spending by avoiding the top-five commonly ordered, low-evidence interventions in each of their specialties.

Nearly 90% of the primary care “don’t” savings, or $5.8 billion, would come from prescribing generic, rather than brand-name, statins when starting lipid-lowering therapy, according to research published online Oct. 1 in Archives of Internal Medicine.

My latest. Read the whole shebang.